Overview of COVID-19

Cause and Transmission

Coronavirus disease-19 (COVID-19) is caused by the SARS-CoV-2 virus, which spreads primarily through respiratory droplets and close contact between individuals.

Major Organs Affected

The virus primarily impacts several major organs, including the lungs, heart, kidneys, genitals, and liver. Severe cases can lead to respiratory distress and carry a significant risk of mortality.

Risk Factors for Severe Illness

While even healthy individuals can develop severe COVID-19, the likelihood of critical illness and death increases with age. Men are more frequently affected than women, and certain ethnic groups, particularly Black and Hispanic individuals in the United States, face a higher risk. Additional factors contributing to severe disease include:

– Cardiovascular disease
– Diabetes mellitus
– Immunosuppression
– Obesity

Understanding Severe COVID-19

Initial Symptoms

The initial symptoms of COVID-19 often include fever, cough, fatigue, headaches, muscle pain, and diarrhea. Statistically, about 5% of symptomatic patients will become critically ill, while 14% may experience severe illness. The duration of symptoms and complications varies widely, with severe cases typically emerging about a week after symptoms begin.

Diagnosis of Severe COVID-19

Severe COVID-19 is characterized by:

– A respiratory rate of at least 30 breaths per minute
– Blood oxygen saturation of 93% or less
– An oxygenation index of 300 mmHg
– Lung imaging showing infiltrates in more than 50% of the lung field

Dyspnea, or shortness of breath, is the most prevalent symptom in severe cases, affecting 40% of symptomatic patients. Many also experience hypoxemia and may face progressive respiratory failure and other complications.

Treatment for Severe COVID-19

Diagnosis Methods

Diagnosis of COVID-19 can be established through:

– The patient’s clinical history
– Detection of SARS-CoV-2 RNA in respiratory secretions
– Identification of bilateral consolidations on chest radiography

Following diagnosis, hospitalization for close monitoring is essential, often in an intensive care unit (ICU).

Monitoring and Support

Patients in the ICU are closely monitored using pulse oximetry. Oxygen supplementation using a nasal cannula or Venturi mask is critical to maintaining hemoglobin oxygen saturation levels between 90-96%. Various procedures, including endotracheal intubation and bronchoscopy, may be employed to support respiratory function.

Protective Equipment and Patient Care

Healthcare providers must use appropriate personal protective equipment (PPE) when treating COVID-19 patients. Patients are also encouraged to wear surgical masks to minimize the risk of spreading the virus.

Endotracheal Intubation

Deciding when to perform endotracheal intubation is crucial. This procedure involves inserting a flexible plastic tube into the trachea to secure an open airway. Following intubation, lung-protective ventilation is necessary, with specific guidelines for pressure and tidal volumes.

Medications Used

Sedatives and analgesics may be administered to alleviate pain and distress. Dexamethasone has emerged as a standard treatment, significantly reducing mortality rates among patients requiring oxygen, particularly those on mechanical ventilation. A major clinical trial indicated a 17% reduction in mortality with its use.

Antiviral Treatments

Remdesivir has been authorized by the FDA for COVID-19 treatment in hospitalized patients, although further research is needed to fully understand its efficacy against severe cases. The combination of dexamethasone and remdesivir is being increasingly utilized, pending more clinical trial data. Other antiviral agents, such as lopinavir and ritonavir, are also under evaluation.

Criteria for Discharge

Patients can only be discharged from the ICU once specific criteria are met, including:

– Absence of fever for at least three days
– Significant improvement in respiratory symptoms
– Chest scans indicating reduced lesions
– No life-threatening damage to major organs

Strict adherence to infection-control guidelines and prompt establishment of care goals are critical for managing the risk of complications associated with severe COVID-19.

References

Berlin, D., Gulick, R., and Martinez, F. (2020). Severe Covid-19. The New England Journal of Medicine, 383 (25), 2451-2460. Retrieved from: https://www.nejm.org/doi/full/10.1056/NEJMcp2009575?query=featured_home

Xie, P., et al. (2020). Severe Covid-19: a review of recent progress with a look toward the future. Frontiers in Public Health, 8, 189. Retrieved from: https://doi.org/10.3389/fpubh.2020.00189

Image by Miguel Á. Padriñán from Pixabay